BACKGROUND: Data on coronary plaque observations on multi-slice computed tomography (MSCT) in patients with type 2 diabetes are scarce. METHODS AND RESULTS: In total, 60 patients (19 with diabetes) underwent 64-slice MSCT, followed by conventional coronary angiography with intravascular ultrasound (IVUS). Non-invasively, the extent of coronary atherosclerosis and 3 plaque types (non-calcified, calcified, mixed) were visually evaluated on MSCT. Invasively, plaque burden was assessed on gray-scale IVUS. Plaque composition was evaluated on virtual histology intravascular ultrasound (VH IVUS). Concerning geometrical plaque data, diabetic patients showed more plaques on MSCT (7.1 +/- 3.2 vs 4.9 +/- 3.2 in non-diabetic patients, P = .01). On gray-scale IVUS, diabetes was associated with a larger plaque burden (48.7 +/- 10.7% vs 40.0 +/- 12.1%, P = .003). Concerning plaque composition, diabetes was associated with more calcified plaques on MSCT (52% vs 24%). Relatively more fibrocalcific plaques in diabetic patients (29% versus 9%) were observed on VH IVUS. Moreover, these plaques contained more necrotic core (10.8 +/- 5.9% vs 8.6 +/- 5.2%, P = .01). CONCLUSION: A higher plaque extent and more calcified lesions were observed in diabetic patients on MSCT. The findings were confirmed on gray-scale and VH IVUS. Thus, MSCT may potentially be used to explore patterns of coronary atherosclerosis in diabetic patients.
BACKGROUND: Data on coronary plaque observations on multi-slice computed tomography (MSCT) in patients with type 2 diabetes are scarce. METHODS AND RESULTS: In total, 60 patients (19 with diabetes) underwent 64-slice MSCT, followed by conventional coronary angiography with intravascular ultrasound (IVUS). Non-invasively, the extent of coronary atherosclerosis and 3 plaque types (non-calcified, calcified, mixed) were visually evaluated on MSCT. Invasively, plaque burden was assessed on gray-scale IVUS. Plaque composition was evaluated on virtual histology intravascular ultrasound (VH IVUS). Concerning geometrical plaque data, diabeticpatients showed more plaques on MSCT (7.1 +/- 3.2 vs 4.9 +/- 3.2 in non-diabeticpatients, P = .01). On gray-scale IVUS, diabetes was associated with a larger plaque burden (48.7 +/- 10.7% vs 40.0 +/- 12.1%, P = .003). Concerning plaque composition, diabetes was associated with more calcified plaques on MSCT (52% vs 24%). Relatively more fibrocalcific plaques in diabeticpatients (29% versus 9%) were observed on VH IVUS. Moreover, these plaques contained more necrotic core (10.8 +/- 5.9% vs 8.6 +/- 5.2%, P = .01). CONCLUSION: A higher plaque extent and more calcified lesions were observed in diabeticpatients on MSCT. The findings were confirmed on gray-scale and VH IVUS. Thus, MSCT may potentially be used to explore patterns of coronary atherosclerosis in diabeticpatients.
Authors: G S Mintz; S E Nissen; W D Anderson; S R Bailey; R Erbel; P J Fitzgerald; F J Pinto; K Rosenfield; R J Siegel; E M Tuzcu; P G Yock Journal: J Am Coll Cardiol Date: 2001-04 Impact factor: 24.094
Authors: Anuja Nair; Barry D Kuban; E Murat Tuzcu; Paul Schoenhagen; Steven E Nissen; D Geoffrey Vince Journal: Circulation Date: 2002-10-22 Impact factor: 29.690
Authors: Joanne D Schuijf; Jeroen J Bax; Liesbeth P Salm; J Wouter Jukema; Hildo J Lamb; Ernst E van der Wall; Albert de Roos Journal: Am J Cardiol Date: 2005-03-01 Impact factor: 2.778
Authors: Gabija Pundziute; Joanne D Schuijf; J Wouter Jukema; Eric Boersma; Arthur J H A Scholte; Lucia J M Kroft; Ernst E van der Wall; Jeroen J Bax Journal: Diabetes Care Date: 2007-01-26 Impact factor: 19.112
Authors: Joanne D Schuijf; Gabija Pundziute; J Wouter Jukema; Hildo J Lamb; Bas L van der Hoeven; Albert de Roos; Ernst E van der Wall; Jeroen J Bax Journal: Am J Cardiol Date: 2006-05-19 Impact factor: 2.778
Authors: K Nasu; E Tsuchikane; O Katoh; H Fujita; J-F Surmely; M Ehara; Y Kinoshita; N Tanaka; T Matsubara; Y Asakura; K Asakura; M Terashima; T Suzuki Journal: Heart Date: 2007-07-23 Impact factor: 5.994
Authors: R Kornowski; G S Mintz; A J Lansky; M K Hong; K M Kent; A D Pichard; L F Satler; J J Popma; T A Bucher; M B Leon Journal: Am J Cardiol Date: 1998-06-01 Impact factor: 2.778
Authors: Joëlla E van Velzen; Fleur R de Graaf; Michiel A de Graaf; Joanne D Schuijf; Lucia J Kroft; Albert de Roos; Johan H C Reiber; Jeroen J Bax; J Wouter Jukema; Eric Boersma; Martin J Schalij; Ernst E van der Wall Journal: J Nucl Cardiol Date: 2011-07-19 Impact factor: 5.952
Authors: Marije M G Krul; Kjell Bogaard; Remco J J Knol; Albert C van Rossum; Paul Knaapen; Jan H Cornel; Friso M van der Zant Journal: BMJ Open Diabetes Res Care Date: 2014-04-23
Authors: Theodor Baars; Thomas Konorza; Philipp Kahlert; Stefan Möhlenkamp; Raimund Erbel; Gerd Heusch; Petra Kleinbongard Journal: Cardiovasc Diabetol Date: 2013-01-10 Impact factor: 9.951